U.S. drug price negotiation already affecting Bristol Myers, Pfizer, AbbVie
Biotechnology Innovation Organization (BIO) members Bristol Myers’, Pfizer’s, and AbbVie’s drugs “are likely to be among 10 big-selling medicines subject to U.S. price negotiations […]
U.S. drug price negotiation already affecting Bristol Myers, Pfizer, AbbVie Read More »